Report License

$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off

Order Review

Erythropoietin Drugs Market – By Drug Type (Biosimilars, First-Generation, Second-Generation Formulation), Drug Class (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa), Application (Cancer, Renal), Distribution Channel - Global Forecast 2024 – 2032

Report ID: GMI10624
Selected License: $8,350
Discount: $2,505
Order Total: $5,845

Need assistance?

Call us or write to us:

What You Get?

Billing Information

Payment Method


creditCardImage
Top